If This Pill Prevents HIV, Why Is No One Taking It?

The Leonard Lopate Show | Jan 30, 2014

It’s been over a year since The FDA approved Truvada, a once a day medication that prevents HIV infection. But why are so few people taking it? Dr. Robert Grant, a professor at the University of California San Francisco, talks about the drug and why it’s slow to catch on. He’s the lead scientist who developed the treatment, which is known as “pre-exposure prophylaxis” or PrEP.

WNYC is funded by sponsors and member donations

WNYC Homepage - Top Stories

Jack Schlossberg, the Kennedy Running for Congress in New York. Plus, the Astronaut Reid Wiseman

The candidate on the role of social media in politics, and speaking out against his cousin R.F.K., Jr. Plus, the commander of NASA’s Artemis II mission on the dark side of the moon.

The New Yorker Radio Hour |

NJ Gov. Sherrill: If state police were too aggressive at Delaney Hall, we'll look into it

New Jersey Gov. Mikie Sherrill took call after call Wednesday night from people who told her state police had been overly aggressive in violent clashes with protesters outside the Delaney Hall immigration detention center this weekend.

Ask Governor Sherrill |

I.C.E.'s "Wartime Recruitment" Campaign

Hiring at the highest-funded U.S. law enforcement agency.

On the Media |

Ask the Mayor Recap and More News From City Hall

Elizabeth Kim discusses the issues Mayor Mamdani talked about in his first "ask the mayor" segment.

The Brian Lehrer Show |